SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol 2012;27:540-546.
  • 2
    Guarrera JV, Henry SD, Chen SW, Brown T, Nachber E, Arrington B, et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res 2011;167:e365-e373.
  • 3
    Henry SD, Nachber E, Tulipan J, Stone J, Bae C, Reznik L, et al. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant 2012;12:2477-2486.
  • 4
    Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010;16:874-884.
  • 5
    El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250:691-697.
  • 6
    Jamieson RW, Zilvetti M, Roy D, Hughes D, Morovat A, Coussios CC, Friend PJ. Hepatic steatosis and normothermic perfusion—preliminary experiments in a porcine model. Transplantation 2011;92:289-295.
  • 7
    Boyles TH, Johnson S, Garrahan N, Freedman AR, Williams GT. A validated method for quantifying macrovesicular hepatic steatosis in chronic hepatitis C. Anal Quant Cytol Histol 2007;29:244-250.
  • 8
    Li M, Song J, Mirkov S, Xiao SY, Hart J, Liu W. Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. Hum Pathol 2011;42:356-360.
  • 9
    Marsman H, Matsushita T, Dierkhising R, Kremers W, Rosen C, Burgart L, Nyberg SL. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004;35:430-435.
  • 10
    Zaitoun AM, Al Mardini H, Awad S, Ukabam S, Makadisi S, Record CO. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol 2001;54:461-465.
  • 11
    Caselles V, Kimmel R, Sapiro G. Geodesic active contours. Int J Comput Vis 1997;22:61-79.
  • 12
    Gunn SR, Nixon MS. A robust snake implementation; a dual active contour. IEEE Trans Pattern Anal Mach Intell 1997;19:63-68.
  • 13
    Kass M, Witkin A, Terzopoulos D. Snakes: active contour models. Int J Comput Vis 1988;1:321-331.
  • 14
    Fatakdawala H, Xu J, Basavanhally A, Bhanot G, Ganesan S, Feldman M, et al. Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology. IEEE Trans Biomed Eng 2010;57:1676-1689.
  • 15
    Cumani A. Edge detection in multispectral images. Graphical Models Image Process 1991;53:40-51.
  • 16
    Sapiro G. Color snakes. Comput Vis Image Underst 1997;68:247-253.
  • 17
    Yang L, Meer P, Foran DJ. Unsupervised segmentation based on robust estimation and color active contour models. IEEE Trans Inf Technol Biomed 2005;9:475-486.
  • 18
    Rousseeuw P. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 1987;20:53-65.
  • 19
    Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Mellish CS, ed. IJCAI-1995 Proceedings of the 14th International Joint Conference on Artificial Intelligence. Vol 2. San Mateo, CA: Morgan Kaufmann; 1995:1137-1143.
  • 20
    Nativ NI, Maguire TJ, Yarmush G, Brasaemle DL, Henry SD, Guarrera JV, et al. Liver defatting: an alternative approach to enable steatotic liver transplantation. Am J Transplant 2012;12:3176-3183.
  • 21
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al.; for Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
  • 22
    Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, et al. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl 2013;19:437-449.
  • 23
    D'Alessandro E, Calabrese F, Gringeri E, Valente M. Frozen-section diagnosis in donor livers: error rate estimation of steatosis degree. Transplant Proc 2010;42:2226-2228.
  • 24
    Heller B, Peters S. Assessment of liver transplant donor biopsies for steatosis using frozen section: accuracy and possible impact on transplantation. J Clin Med Res 2011;3:191-194.
  • 25
    Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res 2009;152:54-60.
  • 26
    Berendsen TA, Izamis ML, Xu H, Liu Q, Hertl M, Berthiaume F, et al. Hepatocyte viability and adenosine triphosphate content decrease linearly over time during conventional cold storage of rat liver grafts. Transplant Proc 2011;43:1484-1488.
  • 27
    Vogel T, Brockmann JG, Coussios C, Friend PJ. The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev (Orlando) 2012;26:156-162.